← Back to Clinical Trials
Recruiting NCT05893524

NCT05893524 Uppsala-Dalarna Dementia and Gait Project

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05893524
Status Recruiting
Phase
Sponsor Dalarna University
Condition Dementia
Study Type OBSERVATIONAL
Enrollment 550 participants
Start Date 2015-04-09
Primary Completion 2026-12-24

Trial Parameters

Condition Dementia
Sponsor Dalarna University
Study Type OBSERVATIONAL
Phase N/A
Enrollment 550
Sex ALL
Min Age 37 Years
Max Age 94 Years
Start Date 2015-04-09
Completion 2026-12-24
Interventions
Timed Up-and-Go (TUG single-task)Timed Up-and-Go dual-task (TUGdt)Clinical functional assessment

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

UDDGait™ is a multidisciplinary research project with the overreaching goal of providing an aid for early identification of cognitive impairment and risk of dementia development, thereby providing a basis for adequate symptom relieving and health promoting interventions. A new concept is investigated for this purpose: a "dual-task-test", which implies the combination of a well-established mobility test (Timed Up-and-Go, TUG) with a simultaneous verbal task (i.e. TUG dual-task, TUGdt). This type of test has been judged as a potential aid for early identification of dementia disease. More research is needed to further examine the test's validity, reliability and predictive capacity. The overall aim is to investigate if TUGdt is useful as an aid for prediction of dementia disease. To ensure the results, the aim is also to evaluate the test's measurement properties and to generate normative reference values of healthy control persons.

Eligibility Criteria

Inclusion Criteria: * Patients undergoing memory assessment at at Uppsala University Hospital, Sweden * Patients undergoing memory assessment at at Falu Hospital, Sweden * Cognitively unimpaired individuals with a Mini Mental State Examination (MMSE) score of \> 26 Exclusion Criteria: * Inability to walk three meters back and forth * Inability to rise from a sitting position * Indoor use of a walking aid * Current or recent hospitalization (within the last 2 weeks) * Need of an interpreter to communicate in Swedish

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology